Dermatology News

DALLAS — In this video from the American Association of Hip and Knee Surgeons Annual Meeting, Robert A. Burnett, MD, discussed results that showed repeat mesh glue dressing exposure yielded a fivefold increased risk of allergic dermatitis.

Roflumilast foam 0.3% improved patient-reported outcomes in scalp and body psoriasis, according to a poster presentation at the Fall Clinical Dermatology Conference.

Patients with recessive dystrophic epidermolysis bullosa experienced a reduction in pain and itch with pregabalin treatment, according to small study.

Researchers found various trends in melanoma incidence among young patients, one of which is that rates are steadily decreasing, according to a study.

Earlier this year, the National Psoriasis Foundation published an extensive report on the health impacts of psoriasis, including data on social stigma associated with the disease, health disparities and comorbidities.

WASHINGTON — Patients with inflammatory arthritis who receive rituximab, interleukin-6 inhibition or Janus kinase inhibitors demonstrate higher severe infection risks vs. TNF inhibitors, according to data presented at ACR Convergence 2024.

Patients with cancer who received immune checkpoint inhibitors exhibited increased risk for psoriasis compared with those treated with chemotherapy or targeted therapy.

WASHINGTON — Dactylitis, psoriasis and other non-musculoskeletal manifestations of psoriatic arthritis can be accurately monitored through patient self-reporting, according to data presented at ACR Convergence 2024.

A novel, six-step skincare regimen comprised of a “wish list” of ingredients improved the signs of photoaging in men and women, according to a study.